{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:51:17Z","timestamp":1793832677284,"version":"4.6.1"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"38","license":[{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014091","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016545","name":"Roche Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck Sharpe and Dohme"},{"name":"Cardiovascular Research\u2014Zurich Heart House"},{"name":"Lindenhof Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Dipeptidyl peptidase 3 (DPP3) is a protease involved in the degradation of angiotensin II which disturbs peripheral blood pressure regulation and compromises left ventricular function. This study examined the relationship of circulating DPP3 (cDPP3) with cardiogenic shock (CS) and mortality in patients presenting with acute coronary syndromes (ACS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma cDPP3 levels were assessed at baseline and 12\u201324 h after presentation in patients with ACS prospectively enrolled into the multi-centre SPUM-ACS study (n = 4787).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Circulating DPP3 levels were associated with in-hospital CS when accounting for established risk factors including the ORBI risk score [per log-2 increase, hazard ratio (HR) 1.38, 95% confidence interval (CI) 1.05\u20131.82, P = .021]. High cDPP3 was an independent predictor of mortality at 30 days (HR 1.87, 95% CI 1.36\u20132.58, P &amp;lt; .001) and at one year (HR 1.61, 95% CI 1.28\u20132.02, P &amp;lt; .001) after adjustment for established risk factors and the GRACE 2.0 score. Compared to values within the normal range, persistently elevated cDPP3 levels at 12\u201324 h were associated with 13.4-fold increased 30-day mortality risk (HR 13.42, 95% CI 4.86\u201337.09, P &amp;lt; .001) and 5.8-fold increased 1-year mortality risk (HR 5.79, 95% CI 2.70\u201312.42, P &amp;lt; .001). Results were consistent across various patient subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study identifies cDPP3 as a novel marker of CS and increased mortality in patients with ACS. Circulating DPP3 offers prognostic information beyond established risk factors and improves early risk assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehad545","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:08:19Z","timestamp":1692144499000},"page":"3859-3871","source":"Crossref","is-referenced-by-count":61,"title":["Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes"],"prefix":"10.1093","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6654-9918","authenticated-orcid":false,"given":"Florian A","family":"Wenzl","sequence":"first","affiliation":[{"name":"Center for Molecular Cardiology, University of Zurich , Schlieren , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0019-0273","authenticated-orcid":false,"given":"Francesco","family":"Bruno","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular and Thoracic Department, Molinette Hospital, Citt\u00e0 della Salute e della Scienza , Turin , Italy"},{"name":"Royal Brompton and Harefield Hospitals , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8245-7287","authenticated-orcid":false,"given":"Simon","family":"Kraler","sequence":"additional","affiliation":[{"name":"Center for Molecular Cardiology, University of Zurich , Schlieren , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Klingenberg","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kerckhoff Heart and Thorax Center, and Campus of the Justus Liebig University of Giessen , Giessen , Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site Rhine-Main , Bad Nauheim , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-9493","authenticated-orcid":false,"given":"Alexander","family":"Akhmedov","sequence":"additional","affiliation":[{"name":"Center for Molecular Cardiology, University of Zurich , Schlieren , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4358-6411","authenticated-orcid":false,"given":"Stefano","family":"Ministrini","sequence":"additional","affiliation":[{"name":"Center for Molecular Cardiology, University of Zurich , Schlieren , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0467-7708","authenticated-orcid":false,"given":"Karine","family":"Santos","sequence":"additional","affiliation":[{"name":"4TEEN4 Pharmaceuticals GmbH , Hennigsdorf , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Godly","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Godly","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3089-1222","authenticated-orcid":false,"given":"David","family":"Niederseer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Manka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich , Zurich , Switzerland"},{"name":"Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bergmann","sequence":"additional","affiliation":[{"name":"4TEEN4 Pharmaceuticals GmbH , Hennigsdorf , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0523-0695","authenticated-orcid":false,"given":"Giovanni G","family":"Camici","sequence":"additional","affiliation":[{"name":"Center for Molecular Cardiology, University of Zurich , Schlieren , Switzerland"},{"name":"Department of Research and Education, University Hospital Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1666-2266","authenticated-orcid":false,"given":"Arnold","family":"von Eckardstein","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry, University Hospital Zurich and University of Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3058-6407","authenticated-orcid":false,"given":"Barbara","family":"St\u00e4hli","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2441-5799","authenticated-orcid":false,"given":"Olivier","family":"Muller","sequence":"additional","affiliation":[{"name":"Service of Cardiology, Lausanne University Hospital , Lausanne , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3051-0170","authenticated-orcid":false,"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Geneva University Hospital , Geneva , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0824-3026","authenticated-orcid":false,"given":"Lorenz","family":"R\u00e4ber","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiovascular Center, University Hospital Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5259-538X","authenticated-orcid":false,"given":"Thomas F","family":"L\u00fcscher","sequence":"additional","affiliation":[{"name":"Center for Molecular Cardiology, University of Zurich , Schlieren , Switzerland"},{"name":"Royal Brompton and Harefield Hospitals , London , UK"},{"name":"National Heart and Lung Institute, Imperial College , Guy Scadding Building, London , UK"},{"name":"School of Cardiovascular Medicine and Sciences, Kings College London , Strand, London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,26]]},"reference":[{"key":"2023101203214384300_ehad545-B1","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199687039.001.0001","volume-title":"The ESC Textbook of Intensive and Acute Cardiovascular Care","author":"Tubaro","year":"2015"},{"key":"2023101203214384300_ehad545-B2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/jama.294.4.448","article-title":"Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock","volume":"294","author":"Babaev","year":"2005","journal-title":"JAMA"},{"key":"2023101203214384300_ehad545-B3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.108.814947","article-title":"Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective","volume":"119","author":"Goldberg","year":"2009","journal-title":"Circulation"},{"key":"2023101203214384300_ehad545-B4","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJM199904153401504","article-title":"Temporal trends in cardiogenic shock complicating acute myocardial infarction","volume":"340","author":"Goldberg","year":"1999","journal-title":"N Engl J Med"},{"key":"2023101203214384300_ehad545-B5","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/eurheartj\/ehq220","article-title":"Shock in acute myocardial infarction: the Cape Horn for trials?","volume":"31","author":"Thiele","year":"2010","journal-title":"Eur Heart J"},{"key":"2023101203214384300_ehad545-B6","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","article-title":"Cardiogenic shock: current concepts and improving outcomes","volume":"117","author":"Reynolds","year":"2008","journal-title":"Circulation"},{"key":"2023101203214384300_ehad545-B7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.116.07357","article-title":"Novel therapeutic role for dipeptidyl peptidase III in the treatment of hypertension","volume":"68","author":"Pang","year":"2016","journal-title":"Hypertension"},{"key":"2023101203214384300_ehad545-B8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ejhf.1601","article-title":"Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics","volume":"22","author":"Deniau","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2023101203214384300_ehad545-B9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/bbrc.2000.2827","article-title":"Identification of dipeptidyl peptidase III in human neutrophils","volume":"273","author":"Hashimoto","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2023101203214384300_ehad545-B10","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1172\/JCI65698","article-title":"Peptidases released by necrotic cells control CD8+ T cell cross-priming","volume":"123","author":"Gamrekelashvili","year":"2013","journal-title":"J Clin Invest"},{"key":"2023101203214384300_ehad545-B11","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1111\/j.1742-4658.2011.08275.x","article-title":"Dipeptidyl peptidase III: a multifaceted oligopeptide N-end cutter","volume":"278","author":"Prajapati","year":"2011","journal-title":"FEBS J"},{"key":"2023101203214384300_ehad545-B12","doi-asserted-by":"crossref","first-page":"974035","DOI":"10.3389\/fcvm.2022.974035","article-title":"DPP3: from biomarker to therapeutic target of cardiovascular diseases","volume":"9","author":"Ye","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2023101203214384300_ehad545-B13","article-title":"Generation of ACE inhibitory dipeptides by pork muscle dipeptidyl peptidases I and III","author":"Sentandreu"},{"key":"2023101203214384300_ehad545-B14","doi-asserted-by":"crossref","first-page":"e0238039","DOI":"10.1371\/journal.pone.0238039","article-title":"Inhibition of circulating dipeptidyl-peptidase 3 restores cardiac function in a sepsis-induced model in rats: a proof of concept study","volume":"15","author":"Deniau","year":"2020","journal-title":"PLoS One"},{"key":"2023101203214384300_ehad545-B15","doi-asserted-by":"crossref","first-page":"100120","DOI":"10.1016\/j.jacadv.2022.100120","article-title":"Advances in the staging and phenotyping of cardiogenic shock","volume":"1","author":"Jentzer","year":"2022","journal-title":"JACC Adv"},{"key":"2023101203214384300_ehad545-B16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1164\/rccm.202010-3873LE","article-title":"Alteration of the renin-angiotensin-aldosterone system in shock: role of the dipeptidyl peptidase 3","volume":"203","author":"Picod","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2023101203214384300_ehad545-B17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13054-021-03471-2","article-title":"Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study","volume":"25","author":"Blet","year":"2021","journal-title":"Crit Care"},{"key":"2023101203214384300_ehad545-B18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1373\/jalm.2018.027995","article-title":"Novel methods for the quantification of dipeptidyl peptidase 3 (DPP3) concentration and activity in human blood samples","volume":"3","author":"Rehfeld","year":"2019","journal-title":"J Appl Lab Med"},{"key":"2023101203214384300_ehad545-B19","doi-asserted-by":"crossref","first-page":"1058235","DOI":"10.3389\/fmed.2022.1058235","article-title":"Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial","volume":"9","author":"van Lier","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2023101203214384300_ehad545-B20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ejhf.1600","article-title":"Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial","volume":"22","author":"Takagi","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2023101203214384300_ehad545-B21","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/eurheartj\/ehac143","article-title":"Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes","volume":"43","author":"Kraler","year":"2022","journal-title":"Eur Heart J"},{"key":"2023101203214384300_ehad545-B22","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/eurheartj\/ehz259","article-title":"Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes","volume":"40","author":"Li","year":"2019","journal-title":"Eur Heart J"},{"key":"2023101203214384300_ehad545-B23","doi-asserted-by":"crossref","first-page":"ehw582","DOI":"10.1093\/eurheartj\/ehw582","article-title":"Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors","volume":"38","author":"Li","year":"2017","journal-title":"Eur Heart J"},{"key":"2023101203214384300_ehad545-B24","first-page":"qcad027","article-title":"Occlusion of the infarct-related coronary artery presenting as acute coronary syndrome with and without ST-elevation: impact of inflammation and outcomes in a real-world prospective cohort","author":"Bruno","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2023101203214384300_ehad545-B25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ahj.2022.01.010","article-title":"Controlled-level EVERolimus in acute coronary syndrome (CLEVER-ACS)\u2014a phase II, randomized, double-blind, multi-center, placebo-controlled trial","volume":"247","author":"Klingenberg","year":"2022","journal-title":"Am Heart J"},{"key":"2023101203214384300_ehad545-B26","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.jacc.2022.08.747","article-title":"Mammalian target of rapamycin inhibition in patients with ST-segment elevation myocardial infarction","volume":"80","author":"St\u00e4hli","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023101203214384300_ehad545-B27","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1093\/eurheartj\/ehy127","article-title":"Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score","volume":"39","author":"Auffret","year":"2018","journal-title":"Eur Heart J"},{"key":"2023101203214384300_ehad545-B28","doi-asserted-by":"crossref","first-page":"101136","DOI":"10.1016\/j.cpcardiol.2022.101136","article-title":"ORBI Score validation as predictor of cardiogenic shock in patients with ST elevation myocardial infarction in two medical centers in Argentina","volume":"48","author":"Bert\u00f3n","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"2023101203214384300_ehad545-B29","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.21037\/atm-21-2905","article-title":"Development of a machine learning model to predict the risk of late cardiogenic shock in patients with ST-segment elevation myocardial infarction","volume":"9","author":"Bai","year":"2021","journal-title":"Ann Transl Med"},{"key":"2023101203214384300_ehad545-B30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9149(67)90023-9","article-title":"Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients","volume":"20","author":"Killip","year":"1967","journal-title":"Am J Cardiol"},{"key":"2023101203214384300_ehad545-B31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7326\/0003-4819-149-9-200811040-00005","article-title":"Ten-year trends in the incidence and treatment of cardiogenic shock","volume":"149","author":"Jeger R","year":"2008","journal-title":"Ann Intern Med"},{"key":"2023101203214384300_ehad545-B32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0735-1097(89)90051-X","article-title":"The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group","volume":"14","author":"Hands","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"2023101203214384300_ehad545-B33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2048872617706503","article-title":"Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients","volume":"7","author":"Obling","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2023101203214384300_ehad545-B34","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2337\/dc23-0012","article-title":"Circulating long noncoding RNA signatures associate with incident diabetes in older adults: a prospective analysis from the VITA cohort study","volume":"46","author":"Wenzl","year":"2023","journal-title":"Diabetes Care"},{"key":"2023101203214384300_ehad545-B35","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.jtha.2023.04.043","article-title":"Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study","volume":"21","author":"Nopp","year":"2023","journal-title":"J Thromb Haemost"},{"key":"2023101203214384300_ehad545-B36","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/joim.13220","article-title":"Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3","volume":"289","author":"Lier","year":"2021","journal-title":"J Intern Med"},{"key":"2023101203214384300_ehad545-B37","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ejhf.2158","article-title":"Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failure","volume":"23","author":"Boorsma EM, Ter Maaten JM, Damman K, van Veldhuisen DJ, Dickstein K, Anker SD, et al","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2023101203214384300_ehad545-B38","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/S2589-7500(19)30195-5","article-title":"Mortality and morbidity 1 year after stopping a remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trial","volume":"2","author":"Koehler","year":"2020","journal-title":"Lancet Digit Health"},{"key":"2023101203214384300_ehad545-B39","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2022.05.055","article-title":"Cathepsin S levels and survival among patients with non-ST-segment elevation acute coronary syndromes","volume":"80","author":"Stamatelopoulos","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023101203214384300_ehad545-B40","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/M17-1540","article-title":"Amyloid-\u03b2 (1\u201340) and mortality in patients with non-ST-segment elevation acute coronary syndrome: a cohort study","volume":"168","author":"Stamatelopoulos","year":"2018","journal-title":"Ann Intern Med"},{"key":"2023101203214384300_ehad545-B41","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/eurheartj\/ehaa375","article-title":"Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction","volume":"42","author":"Hung","year":"2021","journal-title":"Eur Heart J"},{"key":"2023101203214384300_ehad545-B42","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"2023101203214384300_ehad545-B43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(22)02457-6","article-title":"Application of a sex-specific GRACE score in practice\u2014authors\u2019 reply","volume":"401","author":"Wenzl","year":"2023","journal-title":"Lancet"},{"key":"2023101203214384300_ehad545-B44","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(22)01483-0","article-title":"Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation","volume":"400","author":"Wenzl","year":"2022","journal-title":"Lancet"},{"key":"2023101203214384300_ehad545-B45","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet"},{"key":"2023101203214384300_ehad545-B46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1515\/bchm3.1988.369.1.29","article-title":"Dipeptidyl peptidase III from human erythrocytes","volume":"369","author":"Abrami\u0107","year":"1988","journal-title":"Biol Chem Hoppe Seyler"},{"key":"2023101203214384300_ehad545-B47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1515\/hsz-2016-0117","article-title":"Human dipeptidyl peptidase III regulates G-protein coupled receptor-dependent ca2+ concentration in human embryonic kidney 293T cells","volume":"397","author":"Prajapati","year":"2016","journal-title":"Biol Chem"},{"key":"2023101203214384300_ehad545-B48","first-page":"e344","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"2023101203214384300_ehad545-B49","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/eurheartj\/ehac052","article-title":"Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study","volume":"43","author":"Moledina","year":"2022","journal-title":"Eur Heart J"},{"key":"2023101203214384300_ehad545-B50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/heartjnl-2012-302632","article-title":"Evaluation of the NICE mini-GRACE risk scores for acute myocardial infarction using the Myocardial Ischaemia National Audit Project (MINAP) 2003\u20132009: National Institute for Cardiovascular Outcomes Research (NICOR)","volume":"99","author":"Simms","year":"2013","journal-title":"Heart"},{"key":"2023101203214384300_ehad545-B51","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MCC.0000000000000739","article-title":"An outlook on biomarkers in cardiogenic shock","volume":"26","author":"Iborra-Egea","year":"2020","journal-title":"Curr Opin Crit Care"},{"key":"2023101203214384300_ehad545-B52","doi-asserted-by":"crossref","first-page":"e004425","DOI":"10.1136\/bmjopen-2013-004425","article-title":"Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score","volume":"4","author":"Fox","year":"2014","journal-title":"BMJ Open"},{"key":"2023101203214384300_ehad545-B53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"2023101203214384300_ehad545-B54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0009-9120(96)00105-1","article-title":"Release kinetics of serum cardiac troponin I in ischemic myocardial injury","volume":"29","author":"Bertinchant","year":"1996","journal-title":"Clin Biochem"},{"key":"2023101203214384300_ehad545-B55","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1515\/cclm-2014-0475","article-title":"Kinetics of high-sensitivity cardiac troponin T or troponin I compared to creatine kinase in patients with revascularized acute myocardial infarction","volume":"53","author":"Solecki","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"2023101203214384300_ehad545-B56","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"2023101203214384300_ehad545-B57","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrcardio.2010.199","article-title":"The evolving epidemiology of acute coronary syndromes","volume":"8","author":"Ruff","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"2023101203214384300_ehad545-B58","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1161\/CIRCULATIONAHA.117.030798","article-title":"Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015","volume":"136","author":"Puymirat","year":"2017","journal-title":"Circulation"},{"key":"2023101203214384300_ehad545-B59","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/2012.jama.11348","article-title":"Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction","volume":"308","author":"Puymirat","year":"2012","journal-title":"JAMA"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehad545\/51236512\/ehad545.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/38\/3859\/52018089\/ehad545.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/38\/3859\/52018089\/ehad545.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T22:20:24Z","timestamp":1702938024000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/44\/38\/3859\/7249135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,26]]},"references-count":59,"journal-issue":{"issue":"38","published-online":{"date-parts":[[2023,8,26]]},"published-print":{"date-parts":[[2023,10,12]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehad545","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,7]]},"published":{"date-parts":[[2023,8,26]]}}}